Try our beta test site
1451 studies found for:    Open Studies | "Virus Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Virus Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up
Condition: Ebola Virus Disease
Intervention:
2 Not yet recruiting Multiple Treatments for Ebola Virus Disease (EVD)
Condition: Ebola Virus Disease
Interventions: Drug: Azithromycin;   Drug: Sunitinib and Erlotinib;   Drug: Atorvastatin and Irbesartan;   Other: IV fluids and laboratory testing
3 Recruiting A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects.
Condition: Zika Virus Infection
Interventions: Biological: IXIARO;   Biological: YF Vax 17D Strain;   Biological: Zika Virus Purified Inactivated Vaccine (ZPIV)
4 Recruiting ARMS - Rapidly Generated Multivirus-Specific CTLs for the Prophylaxis And Treatment of EBV, CMV, Adenovirus, HHV6, and BK Virus
Condition: Viral Infection
Intervention: Biological: Multi-virus-specific cytotoxic T lymphocytes
5 Not yet recruiting Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)
Condition: BK Virus Infection
Intervention: Biological: Viralym-B
6 Recruiting A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers
Conditions: Parainfluenza;   Respiratory Viral Infections
Intervention: Biological: Sendai virus vaccine
7 Not yet recruiting Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area
Condition: Zika Virus Infection
Interventions: Other: Placebo;   Biological: Zika Virus Purified Inactivated Vaccine (ZPIV)
8 Recruiting Persistence of Zika Virus in Semen After Acute Infection
Conditions: Zika Virus;   Zika Virus Disease;   Virus Shedding;   Transmission
Intervention:
9 Recruiting Understanding Excretion and Infectivity of Zika Virus in Semen During and After Infection
Condition: Zika Virus
Intervention: Other: Semen analysis and semen PCR for Zika virus
10 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine;   Biological: Placebo (1x Leibovitz L-15 medium)
11 Recruiting Evaluating the Infectivity, Safety, and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants and Children 6 to 24 Months of Age
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV LID ΔM2-2 1030s vaccine;   Biological: Placebo
12 Recruiting BK Virus Post-Kidney Transplant: New Practice Versus Traditional Approach
Conditions: BK Virus Infection;   BK Virus Nephropathy
Interventions: Other: New Protocol - BK viremia or BK virus nephropathy;   Other: Standard Protocol - BK viremia or BK virus nephropathy
13 Recruiting Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
Condition: Respiratory Syncytial Virus
Interventions: Drug: Presatovir;   Drug: Placebo
14 Recruiting Study of Transfusion-Transmitted Infections
Condition: Virus Disease
Intervention:
15 Recruiting A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection
Conditions: Respiratory Syncytial Virus Infections;   Virus Diseases
Interventions: Drug: JNJ-53718678;   Drug: Placebo
16 Recruiting Zika Virus Infection's Neonatal and Pediatric Consequences in French Department of America
Condition: Zika Virus Infection on Fetus and Child During the Pregnancy
Interventions: Other: fundus examination;   Other: Head ultrasound
17 Recruiting The Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug Test
Condition: Hepatitis B Virus Infection, Pregnancy
Intervention: Drug: antiviral therapy
18 Recruiting A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children
Condition: Virus Diseases
Intervention: Procedure: Blood draw
19 Recruiting Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza
Condition: Virus Diseases
Interventions: Drug: Danirixin 15 mg FBE;   Drug: Danirixin 50 mg FBE;   Drug: Placebo;   Drug: Oseltamivir 75 mg
20 Recruiting A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: MEDI8897;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.